ABBO News has recently covered a really exciting news on ImmunityBio. ImmunityBio is a biotechnology company that focuses on developing innovative immunotherapies. Edward Cooke the financial analyst wrote that ImmunityBio’s stock (NASDAQ: IBRX) has experienced a remarkable shift of over 30% in the early trading hours on Monday, April 29th, 2024. This biggest change and […]